Shimamura Y, Ikeya T, Marcon N, Mosko JD. Endoscopic diagnosis and treatment of early esophageal squamous neoplasia. World J Gastrointest Endosc 2017; 9(9): 438-447 [PMID: 28979708 DOI: 10.4253/wjge.v9.i9.438]
Corresponding Author of This Article
Jeffrey D Mosko, MD, Division of Gastroenterology, St. Michael’s Hospital, University of Toronto, 30 Bond Street, Toronto, ON M5B1W8, Canada. moskoj@smh.ca
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Endosc. Sep 16, 2017; 9(9): 438-447 Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.438
Endoscopic diagnosis and treatment of early esophageal squamous neoplasia
Yuto Shimamura, Takashi Ikeya, Norman Marcon, Jeffrey D Mosko
Yuto Shimamura, Norman Marcon, Jeffrey D Mosko, Division of Gastroenterology, St. Michael’s Hospital, University of Toronto, Toronto, ON M5B1W8, Canada
Takashi Ikeya, Department of Gastroenterology, St. Luke’s International Hospital, Tokyo 104-8560, Japan
Author contributions: Shimamura Y, Ikeya T, Marcon N and Mosko JD contributed equally to this work; Shimamura Y and Mosko JD provided substantial contribution to conception and design, and wrote the manuscript; Ikeya T and Marcon N provided substantial contribution to acquisition of data, and revising it critically for important intellectual content.
Conflict-of-interest statement: No potential conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jeffrey D Mosko, MD, Division of Gastroenterology, St. Michael’s Hospital, University of Toronto, 30 Bond Street, Toronto, ON M5B1W8, Canada. moskoj@smh.ca
Telephone: +1-416-8645684
Received: March 3, 2017 Peer-review started: March 7, 2017 First decision: April 17, 2017 Revised: May 14, 2017 Accepted: August 16, 2017 Article in press: August 17, 2017 Published online: September 16, 2017 Processing time: 191 Days and 13.4 Hours
Core Tip
Core tip: Esophageal squamous cell carcinoma is one of the leading causes of cancer death. Improving the detection of early stage lesions remains of utmost importance as these lesions can be cured with endoscopic therapy. Endoscopists have many advanced imaging modalities available to assist in risk stratifying lesions. Endoscopic mucosal resection and submucosal dissection remain the standard of care with literature supportive their respective use. Radiofrequency ablation and other endoscopic treatments are currently available although should not be considered first line at this time. As we await improved endoscopic technologies, endoscopists everywhere must remain vigilant in their endoscopic evaluation of the esophagus during each and every endoscopy performed.
